The purpose of this study was to develop realistic phantom models of the intracellular environment of metastatic breast tumour and naïve brain, and using these models determine an analysis metric for quantification of CEST MRI data that is sensitive to only labile proton exchange rate and concentration. The ability of the optimal metric to quantify pH differences in the phantoms was also evaluated.
| INTRODUCTION
Chemical exchange saturation transfer (CEST) is an MRI contrast mechanism that measures changes in signal from water protons owing to their association with other biomolecules and metabolites, particularly via exchange of protons with hydrolysable functional groups such as amides and amines. 1, 2 CEST MRI has the potential to make non-invasive measurements of pH, 3 inform on areas of infiltrating tumour, 4 differentiate tumour from radiation necrosis, 5 and provide information concerning the conformation of proteins. 6 Since the pH of tissues is highly regulated, and numerous pathologies interfere with this regulation, the application of CEST MRI to generate pH maps in vivo has received significant research interest recently. 7 There is a clear need to develop a reliable, non-invasive method of measuring tumour pH in vivo. One hallmark of cancerous tumours is their dysfunctional regulation of pH, 8 leading to an acidotic extracellular space and slight alkalosis in the intracellular space. 9 This change in pH has consequences for the efficacy of various treatments for tumours, and measurement of tumour pH may be useful in stratification of patients based on their expected responsiveness to particular therapies. In particular, brain metastasis, or secondary tumour spread to the brain, represents a major clinical problem, with poor prognosis and few therapeutic options. The development of better methods for interrogating the tumour microenvironment and targeting therapy may greatly enhance our ability to treat these tumours.
It is widely recognized that CEST is sensitive to more than just pH, which has led to various studies offering different explanations for the source of CEST contrast seen in tumours. Some studies claim that an increased protein concentration in tumour cells generates contrast between tumour and surrounding tissue. 10, 11 However, others have measured insignificantly different protein concentration between rodent brain and implanted tumour, and suggest that the contrast is a result of T 1 contamination of the signal. 12 In addition, evidence suggests that the pH and labile proton concentration are difficult to separate from CEST measurements. 13 Despite this difficulty, a metric that is not contaminated by relaxation time changes and only depends on the relevant physiological parameters is needed before the potential of using CEST MRI for pH measurement in tumours can be assessed.
To develop such a metric, previous studies have used simple phantoms with a single exchanging pool of protons. 13, 14 These phantoms allow useful insights into the CEST MRI signal source, but do not adequately represent the complex in vivo intracellular biomolecular environment. Methods such as quantitative CEST (qCEST) 14 and the Omega plot 15 have been used in these phantoms to successfully quantify labile proton exchange rate and concentration independently.
However, these methods require many Z spectra to be acquired with varying saturation parameters, which is impractical in a clinical environment. The apparent relaxation due to exchange (AREX) metric has also been proposed to correct for contamination of CEST effects by T 1 relaxation of water, 12, [16] [17] [18] but this method has not been validated in physiologically relevant phantoms.
The aims of this study, therefore, were the following: (i) to develop novel phantom models from cellular extracts that are representative of the in vivo intracellular environment of both normal brain and brain metastases; (ii) to use these phantoms to determine the sensitivity of the CEST MRI signal as measured by a number of different analysis metrics to changes in pH, labile proton concentration, T 1 and T 2 ; (iii) to identify an optimally specific analysis metric for quantification of CEST MRI data and (iv) to evaluate the ability of the optimal metric to quantify pH differences in these phantoms.
2 | METHODS
| Phantom preparation
Phantoms were prepared to represent the intracellular environment of naïve mouse brain and in vitro cultured 4T1-GFP mouse metastatic breast carcinoma cells. The 4T1-GFP cell line is commonly used as a mouse model of metastatic breast cancer, including studies of metastatic spread to the brain. 19 It is an appropriate tumour model here as previous measurements of human breast cancers have displayed intracellular alkalosis. 20 For the mouse brain phantoms, female BALB/c mice aged 6-8 weeks (n = 6) were terminally anaesthetized with sodium pentobarbital and transcardially perfused with 20 mL 
| Solution NMR experiments
Proton spectra were acquired using a vertical bore 600 MHz (14.1 T) spectrometer (Agilent Technologies, Santa Clara, CA, USA) using a WATERGATE sequence with a relaxation delay of 2 s, an acquisition time of 2 s and 128 transients per free induction decay recorded.
The carrier was centred on water (4.7 ppm) with a sweep width of 9551 Hz. Spectra were processed using NMRPipe. 23 
| MRI experiments
All MRI experiments were performed using a horizontal bore 400 MHz In addition to CEST imaging, the T 1 and T 2 relaxation times of each phantom were measured using inversion recovery (T R = 10 s, 
| MRI data processing
All MRI data were processed in MATLAB (MathWorks, Natick, MA, USA). The relaxation maps of the water pool were obtained by least square fitting of the measured intensity against the inversion time (T 1 map) and echo time (T 2 map). Six metrics were used to analyse the Z spectra: conventional asymmetry analysis (MTR asym ), 1 multiple-offset analysis (APT*), 24 inverse Z-spectrum multiple-offset analysis (MTR Rex ), 12 AREX, 12 and two variants of a Bayesian model-based analysis (CESTR*), 13 as defined in Equations 1-5, respectively. B 0 inhomogeneity was corrected prior to MTR asym , APT* and MTR Rex analysis by shifting the minimum point of the Z spectrum to 0 ppm on a voxel-wise basis; CESTR* corrects for B 0 inhomogeneity during the analysis. All analyses were performed on a voxel-wise basis, and the data presented for each phantom are the mean ± standard deviation for a fixed-area region of interest (ROI) over each phantom.
In Equations 1-5, ω is the offset frequency of interest, Z(ω) is the signal measured following saturation at the frequency ω, Z 0 is the signal measured following saturation at ±100 ppm,
, and S n − pool is the signal from a simulated Z spectrum with n pools, and labile pool properties defined by those measured by a Bayesian model-based algorithm, 13 implemented in BayCEST as part of the FMRIB Software Library (www.fmrib.ox.ac.uk/fsl/baycest). CEST effects were measured for all metrics at ω = 2.8 ppm with δω = 1.4 ppm.
Three pools were fitted using BayCEST: the water pool at 0 ppm (W), the labile amine proton pool at 2.8 ppm (CEST) and an exchange pool centred at −3.5 ppm. BayCEST fits the Bloch-McConnell equations to the measured Z spectra with the exchange rate and relaxation times for each pool defined by Bayesian prior distributions.
BayCEST measures fitted values of the exchange rate and relative concentration of the protons in each pool, and T 1 and T 2 relaxation times for all proton pools (Supplementary Figure S1) . BayCEST was run for each phantom with 'default' values for the mean of the prior distributions for water T 1 (1.8 s) and T 2 (100 ms). Subsequently, the water T 1 and T 2 times measured from each phantom in the T 1 and T 2 maps were included as the means of the associated prior distributions in the model fitting (Supplementary Table S1 ). In both cases the T 1 and T 2 values remained as parameters within the fitting procedure to be estimated from the data.
CESTR* was calculated from the 2.8 ppm pool by simulating onepool (W only) and two-pool (W + CEST) systems using only the fitted estimates of exchange rate and relative concentration, and measuring the difference in signal at 2.8 ppm (Supplementary Figure S2) . This produced two values for CESTR*-one calculated with 'default' priors for water T 1 (1.8 s) and T 2 (100 ms), and a second with phantom specific measured T 1 and T 2 prior means-hereafter called 'CESTR*
with measured T 1 /T 2 priors'. The fitted exchange rate was not used directly, as a degree of correlation exists between the fitted exchange rate and concentration. 13 Further details of the fitting and analysis procedure for CESTR* can be found in the Supplementary Methods.
| Determination of optimal metric
The relationship between the calculated CEST effect using each metric and the serially varied parameters was determined by linear regression, and its absolute value (in |% M 0 |/parameter unit change) compared between phantom models using a t test corrected for multiple comparisons using the Holm-Sidak method. 25 Statistical significance was defined as P < 0.05, which after correction gave an effective significance level of P < 0.003. These comparisons were used to determine whether pooling the data from the two phantom models was appropriate.
Subsequently, a further multi-parameter linear regression model was used to determine the optimal analysis metric in terms of specificity. Data from both phantom models (tumour and naïve brain) were combined and fitted to a model of the form of Equation 6, which describes the response of an ideal CEST quantification metric (i.e. only dependent on pH and [BSA]).
The coefficients α , β , ε of Equation 6 are constants 
| Measurement of pH differences using optimal metric
For the optimal metric, differences in experimentally measured CEST effects were calculated between each pair of phantoms (ΔCEST = CEST1 − CEST2). These differences were tested for statistical significance, defined as a difference larger than the standard deviations on each CEST effect measurement added in quadrature
For statistically significant differences in CEST effect, pH differences as measured by pH probe ('Experimental ΔpH') and back calculated from the linear regression coefficients from Equation 6
('Calculated ΔpH') were correlated to verify the suitability of the metric for measuring pH differences. However, clear differences were seen in the distribution and magnitude of metabolite peaks from PCA-extracted naïve mouse brain and ). Coloured arrows signify relative differences between spectra, and * signifies signal from a contaminant from the PCA extraction procedure.~signifies points where the peaks exceed the axis limits. Numbers are metabolite identification: 1, Lac; 2, NAA; 3, Glu; 4, Gln; 5, NAA; 6, Asp; 7, Cr/PCr; 8, PC/GPC; 9, Tau; 10, Myo-ins; 11, Asc/Gln/Glu/GSH; 12, Cr/PCr in vivo tumour, revealing their distinctly different metabolite compositions ( Figure 1B) . Upon comparing the spectra from the lysate of in vitro cultured 4T1-GFP cells and the representative phantom model (Figure 1C ), the marked similarities in the magnitude of the broad protein lineshapes indicate that the phantom (extract) model is a reasonable approximation of the intracellular environment of 4T1-GFP cells.
Clear differences between the Z spectra from phantoms of BSA only and those containing 4T1-GFP cell PCA extracts were evident in the −1.0 to −5.0 ppm region, and indicates nuclear Overhauser enhancement (NOE)-mediated saturation of the water signal owing to the presence of the intracellular metabolites (Figure 2) . The CEST effect centred at 2.8 ppm is also altered with increasing concentration of PCA-extracted tissue.
| Quantification of CEST effects by multiple metrics
The relationships between the measured CEST effect at 2. Significance levels for all linear regression relationships are shown in Table 1 . Significant decreases in MTR asym , APT* and MTR Rex were observed with increasing pH, which is expected for the fast-exchanging amine protons at this frequency 21 ( Figure 3A .i-C.i). Conversely, however, since CESTR* estimates the exchange rate and concentration directly from the Z spectrum, an increase in CESTR* (calculated with default T 1 /T 2 priors) was seen as pH increased ( Figure 3D .i). The AREX metric also showed a significant decrease as pH increased ( Figure 3E .i), and the increase in CESTR* became significant when measured T 1 /T 2 priors were included ( Figure 3F .i).
Significant increases in all metrics apart from MTR asym were evident with increasing protein concentration ( Figure 3B .ii-F.ii). In contrast, MTR asym decreased as protein concentration increased (Figure 3A. ii). APT*, MTR Rex and CESTR* (default T 1 /T 2 priors) were found to be sensitive to changes in both proton relaxation times in both phantom models ( Figure 3B .iii,iv-D.iii,iv), whilst MTR asym was sensitive only to changes in T 1 in the 4T1-GFP phantom model ( Figure 3A. iii,iv).
Some measurements of MTR Rex and APT* were negative because in these instances the relaxation time change resulted in no discernible CEST peak at 2.8 ppm (see Supplementary Figure S4 ). Since a negative CEST effect measurement is unphysical, these measurements were set to zero. As expected, AREX was insensitive to T 1 relaxation time variations in both phantom models, but sensitive to T 2 time changes ( Figure 3E .iii,iv).
CESTR* (measured T 1 /T 2 priors) was the only metric insensitive to both relaxation times in both models ( Figure 3F .iii,iv).
Significance levels for the comparisons of linear regression gradients between the two phantom models are shown in Table 2 . Significant differences were found between phantom models for MTR asym , APT* and MTR Rex as pH was varied, and for CESTR* with default T 1 /T 2 priors as T 1 time was varied ( Figure 3A .i-C.i,D.iii, P values in Table 2 ). variations, making it difficult to use these metrics for pH estimation. One contributing factor to the low R 2 values observed for MTR asym (0.53), MTR Rex (0.14) and APT* (0.45) may be the significant difference in linear regression gradients between tumour and naïve brain phantom models as pH is varied. However, it is unlikely that this is the only factor, since AREX and CESTR* with default T 1 /T 2 priors both display similarly low R 2 values (0.48 and 0.07 respectively) with non-significant differences between phantom models. On this basis, the optimal metric was found to be CESTR* with measured T 1 /T 2 priors.
| Determination of optimal metric
3.4 | Measuring pH differences using CESTR* Differences in the experimentally measured CESTR* values (with measured T 1 /T 2 priors) from each phantom were measured and FIGURE 2 Z spectra of 8% w/v BSA phantoms at pH 7.2 supplemented with PCA extract from 4T1-GFP cells, replicating metabolite concentrations of 1×, 1.5× or 2× intracellular levels. The 4T1-GFP intracellular metabolites clearly alter the measured Z spectrum from the BSA-only Z spectrum (0×). The CEST effect at 2.8 ppm broadens with increasing metabolite content, consistent with an increasing average chemical exchange rate tested for statistical significance. A total of 28 ΔCESTR* values were found to be significant. For these differences, the experimentally measured ΔpH and the calculated ΔpH using a rearrangement of Equation 6 were correlated ( Figure 5 ). These findings validate CESTR* as a reliable measure of ΔpH by CEST MRI, with a root mean square deviation for the correlation in Figure 5 -and expected quantitative pH accuracy-of 0.6 pH units for the case of no variation in protein concentration. Other studies have suggested that the T 1 contamination of the CEST signal is counteracted by changes in water content in vivo, and that the CEST contrast in tumours originates from a higher mobile protein concentration. 27 If this is the case, it may be difficult to quantify pH in tumours as both the pH and protein concentration may be changing simultaneously. However, as shown by this study and others, 12,28 T 1 correction is absolutely necessary for reliable, specific quantification of the CEST signal, regardless of the counteracting effect of water content. Assuming that the effects of T 1 and water content perfectly cancel may lead to inaccurate quantification of CEST effects in vivo in pathologies where only one of these parameters changes.
MTR asym measured from our phantoms decreased as the protein concentration increased, in contrast to previous studies. 5, 10, 21 This discrepancy can be explained by the difference in saturation parameters used in the studies. In this study, a 7.8 s pulse train with CW equivalent power 0.8 μT was employed, which is preferentially sensitive to slowly exchanging protons. The effect of these saturation parameters is to enhance the NOE effects seen from the BSA and extracted metabolites in the phantoms. As the protein concentration increases, these NOE effects increase more than the CEST effects at 2.8 ppm, leading to a decreasing MTR asym . Other studies employing BSA phantoms 21 or in vivo 5,10 all used much shorter (4 s) and higher powers (1.3-1.5 μT), which are less sensitive to the slowly exchanging NOE effects.
Other methods not examined in this study can also be used to quantify the various contributions to a measured CEST effect, such as qCEST. 14 However, qCEST separates the contributions of labile proton exchange rate and concentration to the Z spectrum by measuring the CEST effect as a function of the saturation power. When applied to a clinical setting this approach is impractical owing to acquisition duration and specific absorption rate (SAR) concerns. In addition, the phantom model used in this study does not include a contribution from macromolecular magnetization transfer, which may remain as a confounding issue in interpreting changes in CEST metrics in vivo.
However, macromolecular magnetization transfer effects can be accounted for by CESTR* with measured T 1 /T 2 priors by including another pool in the BayCEST fitting algorithm.
| Sensitivity of CESTR* to pH changes in tumours
One major result of this phantom study is that CESTR* measurement is dependent on a good choice of prior values of T 1 and T 2 time used by the BayCEST fitting algorithm. This implies that there is insufficient information in a single Z spectrum for the BayCEST algorithm to accurately estimate water T 1 and T 2 times when provided with generic, rather than individually measured, values for the prior distributions.
The CESTR* metric with default T 1 /T 2 priors has been used to identify the ischemic penumbra in acute stroke patients, 7 and to generate quantitative pH maps in healthy volunteers and acute stroke patients. 3 The apparent success of these pH maps (i.e. that the anticipated drop in pH was observed in known stroke regions) may be due to the lack of variation in T 1 across the healthy brain and in the acute stage of stroke.
In addition, the simulated CESTR*-pH calibration in that study was generated using a constant amide concentration of 100 mM.
However, assumptions of constant T 1 and amide concentration may not be valid when assessing tumours. Consequently, accurate estimations of both T 1 and labile proton concentration are necessary for reliable pH quantification in tumours using CESTR*. While T 1 is easy to measure in vivo, the labile proton concentration is much harder to quantify reliably. We have shown in this phantom study that CESTR*, with knowledge of the T 1 time and labile proton concentration, provides a means for immediate, quantitative and non-invasive pH measurement, with an accuracy of 0.6 pH units based on the root mean square deviation of Figure 5 . However, as the ΔpH measurements in Figure 5 were made on phantoms with known BSA concentration, application of this method in vivo is limited. Importantly, the non-significant difference in sensitivities of CESTR* to pH in both FIGURE 5 Correlation between ΔpH calculated using a rearrangement of Equation 6 for statistically significant ΔCESTR* measurements between phantoms, and the ΔpH experimentally measured by pH probe. The R 2 value is 0.61. Cross markers (X) indicate the data points where CESTR* incorrectly predicted the sign of the pH change tumour and normal brain phantoms implies that no manual tumour segmentation should be necessary when evaluating the pH of tumours using CESTR* in vivo.
Extracellular pH acidifications of the order of 0.6 pH units are not uncommon in tumours in vivo. 9 Though intracellular pH changes of this order are rare, there are numerous cellular environments (mitochondria and other organelles) where the pH is very alkaline, and which may contribute to the CEST signal by virtue of the majority of their protein content being largely mobile. 29, 30 The exact contribution of each of these compartments to the CEST signal measured in vivo remains to be elucidated.
| CONCLUSION
Novel, realistic phantom models of the in vivo intracellular environment of brain metastases and naïve mouse brain have been developed to determine an analysis metric for quantification of CEST MRI data that is sensitive to only labile proton exchange rate and concentration. We demonstrate that the CESTR* metric with T 1 and T 2 time compensation overcomes many challenges facing interpretation of CEST MRI data. When combined with prior knowledge of protein concentration, CESTR* with T 1 /T 2 compensation allows quantification of pH differences with a mean accuracy of 0.6 pH units. These results suggest that CEST MRI may enable pH differences between tumour and normal tissue to be quantified in vivo without the need for exogenous contrast agents.
